Field efficacy of fluralaner (Bravecto® chewable tablets) for preventing Babesia canis infection transmitted by Dermacentor reticulatus ticks to dogs

[1]  R. Farkas,et al.  Babesiosis in Southeastern, Central and Northeastern Europe: An Emerging and Re-Emerging Tick-Borne Disease of Humans and Animals , 2022, Microorganisms.

[2]  D. Modrý,et al.  The distribution of Dermacentorreticulatus in the Czech Republic re-assessed: citizen science approach to understanding the current distribution of the Babesiacanis vector , 2022, Parasites & vectors.

[3]  Dorothy Normile,et al.  Flea and tick treatment satisfaction, preference, and adherence reported by cat owners in the US, UK, or France who treated their cats with transdermal fluralaner , 2021, Open veterinary journal.

[4]  A. Bajer,et al.  Monitoring the expansion of Dermacentor reticulatus and occurrence of canine babesiosis in Poland in 2016–2018 , 2021, Parasites & Vectors.

[5]  Leschnik Michael.  Focus on Common Small Animal Vector-Borne Diseases in Central and Southeastern Europe , 2020 .

[6]  Peter J. Krause.  Human babesiosis. , 2019, International journal for parasitology.

[7]  A. Estrada-Peña,et al.  A review of canine babesiosis: the European perspective , 2016, Parasites & Vectors.

[8]  H. Sprong,et al.  Dermacentor reticulatus: a vector on the rise , 2016, Parasites & Vectors.

[9]  Janina Taenzler,et al.  Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs after topical administration of fluralaner spot-on solution , 2016, Parasites & Vectors.

[10]  B. Carcy,et al.  Classification of Babesia canis strains in Europe based on polymorphism of the Bc28.1-gene from the Babesia canis Bc28 multigene family. , 2015, Veterinary parasitology.

[11]  Janina Taenzler,et al.  Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated orally with fluralaner chewable tablets (Bravecto™) , 2015, Parasites & Vectors.

[12]  C. Ducrot,et al.  Questionnaire-based survey on the distribution and incidence of canine babesiosis in countries of Western Europe , 2014, Parasite.

[13]  C Barbui,et al.  What is the European Medicines Agency? , 2012, Epidemiology and Psychiatric Sciences.

[14]  P. Irwin.  Canine babesiosis: from molecular taxonomy to control , 2009, Parasites & Vectors.

[15]  L. Papp,et al.  Clinical manifestations of canine babesiosis in Hungary (63 cases). , 2006, Acta veterinaria Hungarica.

[16]  H. Mehlhorn,et al.  Electron microscopical studies on the development of Babesia canis (Sporozoa) in the salivary glands of the vector tick Dermacentor reticulatus. , 1979, Acta tropica.

[17]  Guideline on statistical principles for veterinary clinical trials , 2010 .

[18]  H. Sager,et al.  Presence of potentially pathogenic Babesia sp. for human in Ixodes ricinus in Switzerland. , 2006, Annals of agricultural and environmental medicine : AAEM.

[19]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[20]  P. Hillyard.  Ticks of North-West Europe. , 1996 .